The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...

The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52 ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹3286.4. The stock has experienced fluctuations ...

shares experienced a downturn, with the price falling by 2.06% to Rs 2819.60 during today's session. The decline positions it among the NIFTY MIDCAP 150 index. The stock's movement has drawn ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

Looking at the universe of stocks we cover at Dividend Channel, on 5/16/25, Coca-Cola Europacific Partners plc (Symbol: CCEP), Smurfit Westrock plc (Symbol: SW), and Glaxosmithkline plc (Symbol ...

Multidisciplinary Committee recommends retail price for GSK's cold medicine: Gireesh Babu, New Delhi Friday, June 13, 2025, 08:00 Hrs [IST] The Multidisciplinary Committee (MDC) o ...